Tag Archives: biologics
Pityriasis rubra pilaris: biologics can help
The experts weigh in on pros and cons of biologics
Access issues due to cost and availability causes disparities in biologics use; cancer risk is minimal and there is much more on the horizon for hidradenitis suppurativa, researchers say at AAD 2018.
Modern medicine – dermatology
Herpes zoster rates stay steady with biologics in psoriasis
Study shows no significant difference in herpes zoster risk between psoriasis patients receiving systemic therapy and those not receiving systemic therapy.
Dermatology Times – Dermatology
Genetic variation may explain why biologics help some patients, but fail others
Psoriasis patients carrying a specific gene experience a significantly better early response to ustekinumab, but are less likely to achieve high rates of response to anti-TNFs.
Dermatology Times – Dermatology
A comparison of plaque psoriasis biologics and biosimilars
Switching from originator to biosimilar shows no significant impact on drug survival in plaque psoriasis, but outcomes differ, researchers report.
Dermatology Times – Dermatology
Atopic dermatitis: Biologics to watch in 2018
Not all biologics have the same safety profile for pregnancies
There are several biologic agents that women of reproductive age can choose from to treat and manage psoriasis, but not all agents have the same safety profile during pregnancy and lactation periods.
Dermatology Times – Dermatology
Paradoxical reactions to biologics provide insight
Paradoxical reactions to biologic treatments can provide clues into related conditions such as granulomatous diseases, genetic polymorphisms and latent infections, says an expert.
Dermatology Times – Dermatology
The biologics buzz
Dermatology experts offer what they know about today’s FDA-approved biologics to treat psoriasis. .
Dermatology Times – Dermatology